SIOUX FALLS, S.D., Dec. 05, 2017 -- Raven Industries (NASDAQ:RAVN) announced today that Rick Parod has been appointed to the Company’s Board of Directors effective immediately.
Mr. Parod served as President, Chief Executive Officer, and Director of Lindsay Corporation (NYSE:LNN) from 2000 until his retirement in December 2017. During his tenure, he led the global expansion of the company by establishing an international footprint, executing strategic acquisitions, and leading the development of several new products and technologies. Prior to his role as CEO of Lindsay Corporation, he served in various leadership and management roles with The Toro Company (NYSE:TTC) and Pacific Scientific Company.
“Rick brings over 30 years of relevant business leadership experience and a deep understanding of public company governance,” said Dan Rykhus, President and CEO of Raven Industries. “He is an excellent addition to our Board of Directors and will provide valuable perspective as we continue to deliver on our long-term strategic objectives.”
Mr. Parod will serve on the Governance and Personnel and Compensation Committees.
About Raven Industries, Inc.
Raven Industries (NASDAQ:RAVN) is dedicated to providing innovative, high-value products and solutions that solve great challenges throughout the world. Raven is a leader in precision agriculture, high-performance specialty films, and lighter-than-air technologies. Since 1956, Raven has designed, produced, and delivered exceptional solutions, earning the company a reputation for innovation, product quality, high performance, and unmatched service. For more information, visit http://ravenind.com.
Contact Information
Margaret Carmody, Director of Communications
Raven Industries, Inc.
+1 (605) 336-2750
Source: Raven Industries


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



